SEC Filing Timeline
10-QMay 07, 2026
Quarterly report
8-KMay 07, 2026
Earnings release · Items 2.02,9.01
DEFA14AApr 17, 2026
Additional proxy
DEF 14AApr 17, 2026
Proxy statement
8-KMar 05, 2026
Termination of agreement · Items 1.02
10-KFeb 24, 2026
Annual report
8-KFeb 24, 2026
Material agreement · Items 1.01,2.02,2.03,9.01
8-KFeb 12, 2026
Material agreement · Items 1.01,9.01
8-KFeb 05, 2026
Executive officer change · Items 5.02
8-KJan 12, 2026
Earnings release · Items 2.02,7.01,9.01
8-KDec 11, 2025
Acquisition/disposition · Items 2.01
Recent News (Finnhub)
3 Promising Genomics & Synthetic Biology Stocks in Spotlight in 2026
Beam Therapeutics (BEAM) Is Up 17.6% After Advancing BEAM-302 Toward Accelerated Approval in AATD
Better Gene-Editing Stock: CRISPR Therapeutics or Beam Therapeutics?
Beam Therapeutics Inc. (BEAM) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript